Multiomics reveal human umbilical cord mesenchymal stem cells improving acute lung injury via the lung-gut axis

Figure 8 Screening of differently expressed metabolites in acute lung injury mice treated with human umbilical cord mesenchymal stem cells (n = 6). A: Statistic of differently expressed metabolites under liquid chromatography-tandem mass spectrometry mode; B: Heatmaps of sham + mesenchymal stem cells (MSCs) group vs sham group; C: Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched by differently expressed metabolites of sham + MSC group vs sham group; D: The lipopolysaccharide (LPS) group vs sham group were used to analyze and display differently expressed metabolites; E: KEGG pathway enriched by differently expressed metabolites of LPS group vs sham group; F: Heatmaps of LPS group vs LPS + MSC group; G: KEGG pathways enriched by differently expressed metabolites of sham + MSC group vs sham group. LPS: Lipopolysaccharide; MSC: Mesenchymal stem cell.